Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
life sciences
medicare
national blog main
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
acquisition
adaptimmune
alex azar
allergan
alliance for aging research
allogeneic
alnylam
amgen
approval
bidding
What
price
3
×
industry
administration
adversity
airport
angry
annual
anti
apocalypse
beats
beds
benefited
celgene
cold
days
dealing
despite
discussed
drug
early
exact
fallout
fear
flu
forecasts
gone
historically
home
j.p
jpm
leaders
losing
notes
obs
pharma
plans
presidential
quarterly
rhetoric
rx
Language
Current search:
price
×
fda
×
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up
